What iron bisglycinate dosing is recommended for an adult with low ferritin (16 ng/mL) who has constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Iron Bisglycinate Dosing for Low Ferritin with Constipation

For an adult with ferritin of 16 ng/mL who struggles with constipation, start with iron bisglycinate 25 mg elemental iron once daily on alternate days (every other day), taken in the morning on an empty stomach with 250-500 mg vitamin C. 1, 2

Why Iron Bisglycinate Is Optimal for Constipation-Prone Patients

Iron bisglycinate chelate offers a critical advantage over ferrous sulfate in patients with gastrointestinal intolerance:

  • Ferrous bisglycinate provides 25 mg elemental iron per tablet and demonstrates significantly better tolerability than ferrous sulfate, with gastrointestinal adverse events comparable to placebo. 3, 4

  • Bioavailability of iron bisglycinate chelate reaches 90.9% compared to 26.7% for ferrous sulfate, meaning lower doses achieve equivalent iron repletion while minimizing GI side effects including constipation. 5

  • In direct comparison studies, iron bisglycinate chelate produced superior ferritin increases at lower doses (15 mg/day bisglycinate vs 40 mg/day ferrous sulfate) with markedly better compliance—73% adequate adherence with bisglycinate versus only 35% with ferrous sulfate. 6

Optimal Dosing Strategy to Minimize Constipation

Alternate-day dosing is superior to daily dosing for both absorption and tolerability:

  • Taking iron every other day increases fractional iron absorption by 33% (21.8% vs 16.3%) compared to consecutive daily dosing, while simultaneously reducing gastrointestinal side effects. 2

  • Daily iron doses ≥60 mg trigger hepcidin elevation that persists 24-48 hours, blocking absorption of subsequent doses by 35-45% and increasing constipation without improving efficacy. 1, 2

  • A single morning dose of 25-50 mg elemental iron on alternate days optimizes the balance between absorption, tolerability, and compliance. 1, 2

Specific Regimen for Your Patient

Given ferritin of 16 ng/mL (severely depleted) and constipation history:

  • Start: Iron bisglycinate 25 mg (one tablet) every other day in the morning on an empty stomach. 1, 4

  • Add: 250-500 mg vitamin C with each iron dose to enhance absorption by forming a soluble chelate. 1

  • Timing: Take 1-2 hours before meals to maximize absorption; if intolerance occurs despite alternate-day dosing, may take with a small amount of food. 1

  • Avoid: Tea, coffee, calcium supplements, or dairy products within 1-2 hours of the iron dose, as these markedly reduce absorption. 3, 1

Expected Response and Monitoring

  • Check hemoglobin at 2 weeks: An increase of ≥10 g/L predicts treatment success with 90% sensitivity and 79% specificity. 1

  • Recheck ferritin at 4 weeks: Ferritin should show measurable improvement; if not, this indicates need for dose adjustment or consideration of IV iron. 1

  • Continue therapy for 3 months after hemoglobin normalizes to fully replenish iron stores, resulting in total treatment duration of approximately 6-7 months. 1

When to Escalate to Intravenous Iron

Consider IV iron if:

  • Ferritin fails to increase after 4 weeks of compliant oral therapy despite alternate-day dosing and vitamin C supplementation. 1

  • Hemoglobin does not rise ≥10 g/L by 2 weeks, which strongly predicts overall treatment failure. 1

  • Constipation remains intolerable despite alternate-day dosing with iron bisglycinate. 1

  • Transferrin saturation remains <20% after an adequate oral trial. 1

Critical Pitfalls to Avoid

  • Do not prescribe daily dosing initially—alternate-day dosing with bisglycinate provides superior absorption and tolerability for constipation-prone patients. 2

  • Do not use modified-release iron preparations, as they release iron beyond the duodenum (primary absorption site) and are classified as "less suitable for prescribing." 1

  • Do not switch to ferrous sulfate expecting better results—bisglycinate has 3.4-fold higher bioavailability and markedly better GI tolerability. 5, 6

  • Do not discontinue therapy when hemoglobin normalizes—continue for an additional 3 months to restore iron stores. 1

Related Questions

Can a patient with an initial ferritin <1 ng/mL achieve a measurable increase in ferritin after one month of daily oral iron bisglycinate chelate 29 mg elemental iron?
Is ferrous sulfate equivalent to Solgar Gentle Iron 25 mg (iron bisglycinate chelate) for a 22‑year‑old woman with iron‑deficiency anemia?
What is the recommended dosage of ferrous bisglycinate for treating iron‑deficiency anemia in adults and children?
What is the preferred iron supplement, ferrous bisglycinate or ferrous sulfate, for pediatric patients with iron deficiency?
What is the best iron supplement for patients after heart surgery?
What is the appropriate diagnosis for a patient meeting DSM‑5 criteria for schizophrenia who also exhibits a catatonic syndrome?
Which antidepressants are suitable for a patient with a selective serotonin reuptake inhibitor allergy (e.g., rash, angio‑edema)?
Male patient with total serum testosterone 15 ng/dL (reference 240‑950 ng/dL) and free testosterone 5.49 pg/mL (reference 4.65‑18.1 pg/mL) – what does this indicate and how should the hypogonadism be evaluated and managed?
Is a single dose of Dukoral (killed whole‑cell Vibrio cholerae vaccine containing recombinant cholera toxin B subunit) effective for protection against cholera and enterotoxigenic Escherichia coli (ETEC)?
What is the likely cause and recommended treatment for submandibular gland swelling that occurs shortly after meals?
Is cetirizine (Reactine) safe for a breastfeeding mother and her healthy full‑term infant?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.